Philip J. Monroe

Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro

David J. Smith, R. L. Bouchal, C DESANCTIS et al. · Neuropharmacology · 1987 · 238 citations

Molecular Pharmacology, Pharmacological Study, Biochemistry +6

Single Enantiomer of YK-4-279 Demonstrates Specificity in Targeting the Oncogene EWS-FLI1

Julie S. Barber-Rotenberg, Saravana P. Selvanathan, Yali Kong et al. · Oncotarget · 2012 · 96 citations · Full text

Characterization of Multiple [³H]5–Hydroxytryptamine Binding Sites in Rat Spinal Cord Tissue

Philip J. Monroe, David J. Smith · Journal of Neurochemistry · 1983 · 79 citations

Neurotransmission, Experimental Pharmacology, Synaptic Signaling +18

Dose-Dependent Pain-Facilitatory and -Inhibitory Actions of Neurotensin Are Revealed by SR 48692, a Nonpeptide Neurotensin Antagonist: Influence on the Antinociceptive Effect of Morphine,

David J. Smith, Alyssa A. Hawranko, Philip J. Monroe et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 73 citations

Ketamine analgesia is not related to an opiate action in the periaqueductal gray region of the rat brain

David J. Smith, Jeannette M. Perrotti, Amy L. Mansell et al. · Pain · 1985 · 48 citations

Pain Medicine, Opiate Action, Anesthetic Mechanism +22